Alan Watt

Company: NodThera
Job title: Chief Scientific Officer
Seminars:
Translational Approaches for the Development of Novel NLRP3 Inhibitors 9:00 am
Explore ex vivo stimulated blood assays for early clinical evaluation of pharmacodynamics Use of the D305N NLRP3 mechanistic mouse model for assessment of in vivo target cover Discuss In vivo disease models for PK/PD assessmentRead more
day: Day One